Methods for claims-based pharmacoeconomic studies in psychosis

PharmacoEconomics
Frank GianfrancescoRichard White

Abstract

Pharmacoeconomic studies using claims data are frequently employed to compare the healthcare costs associated with competing drugs. Different methodological approaches with varying limitations for evaluating claims data are reviewed within the context of psychosis. Intent-to-treat paradigms and mirror-image designs have limitations that can bias comparisons of health resource use and can be addressed through the use of drug treatment episodes. Health resource use is better measured in financial rather than volume amounts, to account for service intensity. However, financial measures reported in claims records need to be carefully chosen. Between-group comparisons are frequently affected by selection bias, and within-group comparisons are often limited by period bias. While selection bias can be addressed by controlling for patient factors such as disease severity, and period bias by controlling for trend, devising appropriate control measures from the limited information in claims data can be challenging. Healthcare data are often skewed, which affects statistical testing. While skewed data are commonly handled through log transformation, this method has serious limitations, potentially distorting pharmacoeconomic comparisons. ...Continue Reading

References

Jan 1, 1991·International Journal of Technology Assessment in Health Care·M F Drummond, L Davies
Nov 1, 1996·Clinical Therapeutics·R RajagopalanE F Sherertz
Jan 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·A M GrayJ Morris
Mar 1, 1997·Clinical Therapeutics·B R Motheral, K A Fairman
Sep 1, 1997·Psychiatric Services : a Journal of the American Psychiatric Association·G VialeB J Lawrence
Feb 12, 1998·Annals of Internal Medicine·X H ZhouS L Hui
Apr 16, 1998·Psychopharmacology·R L DotyJ M Risser
Nov 3, 1998·Biological Psychiatry·D A WirshingW C Wirshing
Feb 25, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·M J SchillerW A Hargreaves
May 7, 1998·PharmacoEconomics·S Byford, S Palmer
Oct 28, 1999·PharmacoEconomics·J D Rizzo, N R Powe
Oct 28, 1999·PharmacoEconomics·H G BirnbaumL Venditti
Apr 2, 2002·The American Journal of Psychiatry·Michael J SernyakRobert Rosenheck

❮ Previous
Next ❯

Citations

Dec 24, 2002·Human Psychopharmacology
Jan 20, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Michael WillisUlf Persson
Sep 22, 2007·Journal of Biopharmaceutical Statistics·Douglas FariesMark Belger
Nov 1, 2006·International Journal of Clinical Practice·F GianfrancescoK Rajagopalan
May 29, 2009·Cost Effectiveness and Resource Allocation : C/E·Douglas E FariesHaya Ascher-Svanum
Jul 21, 2006·Journal of Clinical Psychopharmacology·Frank GianfrancescoRuey-hua Wang
Apr 16, 2014·Current Medical Research and Opinion·Marie-Hélène LafeuillePatrick Lefebvre
Jun 26, 2012·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Marie-Hélène LafeuillePatrick Lefebvre
Apr 25, 2012·Health Services Research·Brent A Metfessel, Robert A Greene
Aug 11, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Frank GianfrancescoJacqueline Pesa
Nov 22, 2019·Irish Journal of Psychological Medicine·P KirwanC McDonald
Jul 26, 2017·Journal of Market Access & Health Policy·Clément FrançoisRobin Tan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.